INTELLIA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
INTELLIA THERAPEUTICS, INC. (NTLA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 824.58 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 93.10K shares, a 16.16% increase year-over-year.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 731.48K shares, a 14.16% increase year-over-year.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 63.00K shares, a 56.84% decline year-over-year.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 783.90K shares, a 14.62% decline from fiscal 2024.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 918.16K shares, a 61.13% increase from fiscal 2023.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 569.82K shares, a 45.40% increase from fiscal 2022.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 391.91K shares, a 85.64% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 8 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 93.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 824.58K shares 10-Q · filed 2026-08-06 | 824.58K shares derived: sum of 3 quarters · filed 2026-08-06 | 887.58K shares derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | 731.48K shares 10-Q · filed 2026-05-11 | 731.48K shares derived: sum of 2 quarters · filed 2026-05-11 | 794.48K shares derived: sum of 3 quarters · filed 2026-05-11 | 874.63K shares derived: sum of 4 quarters · filed 2026-05-11 | |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 63.00K shares derived: sum of 2 quarters · filed 2026-02-26 | 143.15K shares derived: sum of 3 quarters · filed 2026-02-26 | 783.90K shares 10-K · filed 2026-02-26 | |
| 2025-09-30 | 63.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 143.15K shares derived: sum of 2 quarters · filed 2025-11-06 | 783.90K shares 10-Q · filed 2025-11-06 | 783.90K shares derived: sum of 4 quarters · filed 2025-11-06 | |
| 2025-06-30 | 80.15K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 720.90K shares 10-Q · filed 2025-08-07 | 720.90K shares derived: sum of 3 quarters · filed 2025-08-07 | 866.87K shares derived: sum of 4 quarters · filed 2025-08-07 | |
| 2025-03-31 | 640.75K shares 10-Q · filed 2025-05-08 | 640.75K shares derived: sum of 2 quarters · filed 2025-05-08 | 786.72K shares derived: sum of 3 quarters · filed 2025-05-08 | 878.11K shares derived: sum of 4 quarters · filed 2025-05-08 | |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 145.97K shares derived: sum of 2 quarters · filed 2025-02-27 | 237.36K shares derived: sum of 3 quarters · filed 2025-02-27 | 918.16K shares 10-K · filed 2025-02-27 | |
| 2024-09-30 | 145.97K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 237.36K shares derived: sum of 2 quarters · filed 2024-11-07 | 918.16K shares 10-Q · filed 2024-11-07 | 918.16K shares derived: sum of 4 quarters · filed 2024-11-07 | |
| 2024-06-30 | 91.39K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 772.19K shares 10-Q · filed 2024-08-08 | 772.19K shares derived: sum of 3 quarters · filed 2024-08-08 | 772.19K shares derived: sum of 4 quarters · filed 2024-08-08 | |
| 2024-03-31 | 680.80K shares 10-Q · filed 2024-05-09 | 680.80K shares derived: sum of 2 quarters · filed 2024-05-09 | 680.80K shares derived: sum of 3 quarters · filed 2024-05-09 | 737.02K shares derived: sum of 4 quarters · filed 2024-05-09 | |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 0.00 shares derived: sum of 2 quarters · filed 2024-02-22 | 56.22K shares derived: sum of 3 quarters · filed 2024-02-22 | 569.82K shares 10-K · filed 2024-02-22 | |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 56.22K shares derived: sum of 2 quarters · filed 2023-11-09 | 569.82K shares 10-Q · filed 2023-11-09 | 569.82K shares derived: sum of 4 quarters · filed 2023-11-09 | |
| 2023-06-30 | 56.22K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 569.82K shares 10-Q · filed 2023-08-03 | 569.82K shares derived: sum of 3 quarters · filed 2023-08-03 | 569.82K shares derived: sum of 4 quarters · filed 2023-08-03 | |
| 2023-03-31 | 513.61K shares 10-Q · filed 2023-05-04 | 513.61K shares derived: sum of 2 quarters · filed 2023-05-04 | 513.61K shares derived: sum of 3 quarters · filed 2023-05-04 | 585.84K shares derived: sum of 4 quarters · filed 2023-05-04 | |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | 0.00 shares derived: sum of 2 quarters · filed 2023-02-23 | 72.23K shares derived: sum of 3 quarters · filed 2023-02-23 | 391.91K shares 10-K · filed 2023-02-23 | |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 72.23K shares derived: sum of 2 quarters · filed 2022-11-03 | 391.91K shares 10-Q · filed 2022-11-03 | 686.11K shares derived: sum of 4 quarters · filed 2022-11-03 | |
| 2022-06-30 | 72.23K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 391.91K shares 10-Q · filed 2022-08-04 | 686.11K shares derived: sum of 3 quarters · filed 2022-08-04 | 1.13M shares derived: sum of 4 quarters · filed 2022-08-04 | |
| 2022-03-31 | 319.68K shares 10-Q · filed 2022-05-05 | 613.88K shares derived: sum of 2 quarters · filed 2022-05-05 | 1.06M shares derived: sum of 3 quarters · filed 2022-05-05 | 1.40M shares derived: sum of 4 quarters · filed 2022-05-05 | |
| 2021-12-31 | 294.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 735.50K shares derived: sum of 2 quarters · filed 2022-02-24 | 1.08M shares derived: sum of 3 quarters · filed 2022-02-24 | 2.73M shares 10-K · filed 2022-02-24 | |
| 2021-09-30 | 441.30K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 789.28K shares derived: sum of 2 quarters · filed 2021-11-04 | 2.44M shares 10-Q · filed 2021-11-04 | 2.61M shares derived: sum of 4 quarters · filed 2021-11-04 | |
| 2021-06-30 | 347.98K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 1.99M shares 10-Q · filed 2021-08-05 | 2.17M shares derived: sum of 3 quarters · filed 2021-08-05 | 2.38M shares derived: sum of 4 quarters · filed 2021-08-05 | |
| 2021-03-31 | 1.65M shares 10-Q · filed 2021-05-06 | 1.82M shares derived: sum of 2 quarters · filed 2021-05-06 | 2.03M shares derived: sum of 3 quarters · filed 2021-05-06 | 2.52M shares derived: sum of 4 quarters · filed 2021-05-06 | |
| 2020-12-31 | 178.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | 388.65K shares derived: sum of 2 quarters · filed 2021-02-26 | 871.99K shares derived: sum of 3 quarters · filed 2021-02-26 | 2.98M shares 10-K · filed 2021-02-26 | |
| 2020-09-30 | 210.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 693.59K shares derived: sum of 2 quarters · filed 2020-11-05 | 2.80M shares 10-Q · filed 2020-11-05 | 2.96M shares derived: sum of 4 quarters · filed 2020-11-05 | |
| 2020-06-30 | 483.33K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 2.59M shares 10-Q · filed 2020-08-06 | 2.75M shares derived: sum of 3 quarters · filed 2020-08-06 | 3.01M shares derived: sum of 4 quarters · filed 2020-08-06 | |
| 2020-03-31 | 2.10M shares 10-Q · filed 2020-05-07 | 2.27M shares derived: sum of 2 quarters · filed 2020-05-07 | 2.53M shares derived: sum of 3 quarters · filed 2020-05-07 | 2.88M shares derived: sum of 4 quarters · filed 2020-05-07 | |
| 2019-12-31 | 163.14K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | 426.80K shares derived: sum of 2 quarters · filed 2020-02-27 | 774.28K shares derived: sum of 3 quarters · filed 2020-02-27 | 1.22M shares 10-K · filed 2020-02-27 | |
| 2019-09-30 | 263.66K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | 611.14K shares derived: sum of 2 quarters · filed 2019-10-31 | 1.06M shares 10-Q · filed 2019-10-31 | 2.11M shares derived: sum of 4 quarters · filed 2019-10-31 | |
| 2019-06-30 | 347.48K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | 793.81K shares 10-Q · filed 2019-08-01 | 1.85M shares derived: sum of 3 quarters · filed 2019-08-01 | 1.92M shares derived: sum of 4 quarters · filed 2019-08-01 | |
| 2019-03-31 | 446.33K shares 10-Q · filed 2019-05-02 | 1.50M shares derived: sum of 2 quarters · filed 2019-05-02 | 1.58M shares derived: sum of 3 quarters · filed 2019-05-02 | 1.78M shares derived: sum of 4 quarters · filed 2019-05-02 | |
| 2018-12-31 | 1.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | 1.13M shares derived: sum of 2 quarters · filed 2019-02-27 | 1.34M shares derived: sum of 3 quarters · filed 2019-02-27 | 2.13M shares 10-K · filed 2019-02-27 | |
| 2018-09-30 | 78.44K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | 284.32K shares derived: sum of 2 quarters · filed 2018-10-31 | 1.08M shares 10-Q · filed 2018-10-31 | 2.08M shares derived: sum of 4 quarters · filed 2018-10-31 | |
| 2018-06-30 | 205.87K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | 998.29K shares 10-Q · filed 2018-08-01 | 2.00M shares derived: sum of 3 quarters · filed 2018-08-01 | 2.17M shares derived: sum of 4 quarters · filed 2018-08-01 | |
| 2018-03-31 | 792.41K shares 10-Q · filed 2018-05-01 | 1.80M shares derived: sum of 2 quarters · filed 2018-05-01 | 1.97M shares derived: sum of 3 quarters · filed 2018-05-01 | 2.14M shares derived: sum of 4 quarters · filed 2018-05-01 | |
| 2017-12-31 | 1.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | 1.17M shares derived: sum of 2 quarters · filed 2018-03-14 | 1.35M shares derived: sum of 3 quarters · filed 2018-03-14 | 2.69M shares 10-K · filed 2018-03-14 | |
| 2017-09-30 | 167.96K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | 343.03K shares derived: sum of 2 quarters · filed 2017-10-31 | 1.69M shares 10-Q · filed 2017-10-31 | 1.72M shares derived: sum of 4 quarters · filed 2017-10-31 | |
| 2017-06-30 | 175.07K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | 1.52M shares 10-Q · filed 2017-08-01 | 1.55M shares derived: sum of 3 quarters · filed 2017-08-01 | 1.65M shares derived: sum of 4 quarters · filed 2017-08-01 | |
| 2017-03-31 | 1.34M shares 10-Q · filed 2017-05-02 | 1.38M shares derived: sum of 2 quarters · filed 2017-05-02 | 1.48M shares derived: sum of 3 quarters · filed 2017-05-02 | 1.80M shares derived: sum of 4 quarters · filed 2017-05-02 | |
| 2016-12-31 | 35.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | 136.38K shares derived: sum of 2 quarters · filed 2017-03-14 | 453.15K shares derived: sum of 3 quarters · filed 2017-03-14 | 2.61M shares 10-K · filed 2017-03-14 | |
| 2016-09-30 | 101.38K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | 418.15K shares derived: sum of 2 quarters · filed 2016-11-01 | 2.58M shares 10-Q · filed 2016-11-01 | ||
| 2016-06-30 | 316.77K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 2.48M shares 10-Q · filed 2016-08-04 | |||
| 2016-03-31 | 2.16M shares 10-Q · filed 2016-06-03 | ||||
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 0.00 shares 10-Q · filed 2016-08-04 | |||
| 2015-03-31 | 0.00 shares 10-Q · filed 2016-06-03 | ||||
| 2014-12-31 | 0.00 shares 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |